Mirae Asset Global ETFs Holdings’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$544K Buy
149,392
+11,495
+8% +$41.9K ﹤0.01% 1780
2025
Q1
$265K Buy
137,897
+11,517
+9% +$22.1K ﹤0.01% 2177
2024
Q4
$240K Buy
126,380
+12,232
+11% +$23.2K ﹤0.01% 2291
2024
Q3
$151K Buy
+114,148
New +$151K ﹤0.01% 2512